SLC2A1 and lung carcinoma: In addition, the transcriptional coactivator, ANKRD1, activates NF-κB to promote metastasis35, and the glucose transporter, SLC2A1, which is overexpressed in lung cancer, contributes to tumor growth and survival by activating energy metabolism36,37.